
Écrit par TRAN Guy Mong Ky   
Lundi, 09 Décembre 2013 12:13


Présentation Poster au 5°congrès européen de virologie ( Lyon, Septembre 2013)

REF 058         Category: 04. Adaptive immunity and Vaccines

Publié dans Virologie Septembre 2013, vol 17, Supplement S 134



Hebergeur d'image

Hebergeur d'image

Hebergeur d'image


Hebergeur d'image

Hebergeur d'image


V2 loop YxxxWYxxDxxC is conserved in HIV-2.

V3 loop AA sequence is SGLVFH:

Hebergeur d'image

Hebergeur d'image



An AIDS therapeutic vaccine (as was the case for Pasteur anti-rabies vaccine) would be more rapid to develop, step by step, than a classical prophylactic vaccine: The rapidity of a therapeutic vaccine is calculated in months, whereas for a prophylactic vaccine, each trial would take about a dozen of years. The same therapeutic vaccine, when finally successful, can be then converted in a prophylactic vaccine (following the anti-rabies vaccine example).

The scorpion model of AIDS means that there must at least 6 or 7 different AIDS vaccines, as numerous as the number of different geographical species of scorpions. A mannose-based vaccine must be added to the proteins.




Caprani A , Tran GMK and Roudiere L. Use of new targets (D-Mannose receptor, sodium channel voltage dependent) in a new effective, low cost HAART. Validation with the presentation of a clinical case. 17th Int Symp HIV Emerging Inf Dis (ISHEID) 2012, Marseille. Retrovirology 2012, 9 Suppl 1: P13.  Devaux C, Fourquet P, Granier C. A conserved sequence region of scorpion toxins rendered immunogenic induces broadly cross-reactive, neutralizing antibodies. Eur J Biochem. 1996, 242: 727-35. Ekberg J, Craik DJ, Adams DJ. Conotoxin modulation of voltage-gated sodium channels. Int J Biochem Cell Biol. 2008, 40: 2363-8. Review. El Ayeb M, Darbon H, Bahraoui EM, Vargas O, Rochat H. Differential effects of defined chemical modifications on antigenic and pharmacological activities of scorpion alpha and beta toxins. Eur J Biochem. 1986, 155: 289-94. Haynes BF, Gilbert PB, McElrath MJ et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012, 366: 1275-86. Kharrat R, Darbon H, Rochat H, Granier C. Structure/activity relationships of scorpion alpha-toxins. Multiple residues contribute to the interaction with receptors. Eur J Biochem. 1989, 181: 381-90. Pallaghy PK, Alewood D, Alewood PF, Norton RS. Solution structure of robustoxin, the lethal neurotoxin from the funnel-web spider Atrax robustus. FEBS Lett. 1997, 419: 191-6. Possani LD, Merino E, Corona M, Bolivar F, Becerril B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie. 2000, 82: 861-8. Review.  Tran MKG. Homology of HIV 1 gp110 with venoms (scorpion, sea anemone; cobra cytotoxin) whose receptors are ionic channels (Na+ acetylcholine regulated; Ca++). XIX Congress Pediatrics, Paris Jul 1989. Poster M-24. Tran MKG. HIV1 envelope V3 loop mimics scorpion and spider neurotoxins, whose receptor, the Na+ sodium channel, is the target of Tacrine (THA, TetraHydroAminoAcridine). IXth Int. Conf. AIDS, Berlin Jun 1993. Abstr PO-A01-0022. Tran GMK. The scorpion venom model of Aids: Mimicry between anti-V3 loop antibody and the sodium channel the target of Tacrine: A possible vaccine. Europ Aids Clin Soc (EACS), 1997: Abstract 475.  Xue T, Ennis IL, Sato K, French RJ, Li RA. Novel interactions identified between micro-Conotoxin and the Na+ channel domain I P-loop: implications for toxin-pore binding geometry. Biophys J. 2003, 85: 2299-310.  Zolla-Pazner S, deCamp AC, Cardozo T et al.  Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PLoS One. 2013, 8(1): e53629. doi: 10.1371/journal.pone.0053629.

Acknowledgements: Positifs Association.









Mise à jour le Samedi, 28 Décembre 2013 14:36